Manchester, UK 5-7 March

With 25 years of industry experience, Chris Wells is the Capability Owner for ongoing development and strategy of QTLs at Roche Products. Chris has authored many publications, presented at a number of conferences on QTLS/RBQM and is currently co-lead on the PHUSE Working Group, Transcelerate for QTLs, and a member of the EFSPI Working Group. Chris has a B.Sc. in business decision sciences and an M.Sc. in medical statistics.